The fourth edition of the European Code Against Cancer was published by the International Agency for Research on Cancer, with the participation of the European Commission.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY published a revised template for survivorship care plans.
The American Society of Clinical Oncology endorsed a joint clinical practice guideline on molecular testing published by the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
THE ROBERT H. LURIE COMPREHENSIVE CANCER CENTER and the Northwestern Medicine Developmental Therapeutics Institute entered into an alliance with Perthera Inc. to conduct a translational research program designed to assess the utility of integration of next generation sequencing, proteomic, and phospho-proteomic data in oncology developmental therapeutics and clinical practice.
Cancer centers and other hospitals, reeling from the loss of discounts and rebates on three widely used cancer drugs, are seeking to persuade drug maker Genentech to reverse its decision to channel these medications through six specialty distributors.
The Cancer Letter asked Patrick Loehrer, director of the Indiana University Melvin & Bren Simon Cancer Center, to discuss his institution's decision to close its 10-year-old proton beam center.
At its opening a decade ago, the Indiana University Health Proton Therapy Center was one of four such facilities in the U.S.
LISA RICHARDSON was named director of the CDC Division of Cancer Prevention and Control.
MARTINE EXTERMANN received the 2014 Paul Calabresi Award from the International Society of Geriatric Oncology. Extermann is the senior member of the Senior Adult Oncology and Health Outcomes & Behavior Programs at Moffitt Cancer Center.
